![Jim Glasheen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Glasheen
Founder at Clade Therapeutics, Inc.
Jim Glasheen active positions
Companies | Position | Start | End |
---|---|---|---|
Clade Therapeutics, Inc.
![]() Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Director/Board Member | - | - |
Founder | - | - | |
President | - | - | |
CHP Management, Inc.
![]() CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Private Equity Investor | - | - |
First Citizens Bank Ltd.
![]() First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Director/Board Member | - | - |
Career history of Jim Glasheen
Former positions of Jim Glasheen
Companies | Position | Start | End |
---|---|---|---|
Atalanta Therapeutics, Inc.
![]() Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Director/Board Member | 2017-12-31 | 2020-12-30 |
Chief Executive Officer | 2017-12-31 | 2020-12-30 | |
Founder | 2017-12-31 | 2020-12-30 | |
President | 2017-12-31 | 2020-12-30 |
Training of Jim Glasheen
Duke University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistics
International
United States | 6 |
Trinidad and Tobago | 2 |
Operational
Director/Board Member | 3 |
Founder | 2 |
President | 2 |
Sectoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Clade Therapeutics, Inc.
![]() Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
CHP Management, Inc.
![]() CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Finance |
Atalanta Therapeutics, Inc.
![]() Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
First Citizens Bank Ltd.
![]() First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Finance |
- Stock Market
- Insiders
- Jim Glasheen
- Experience